使用BREAST-Q的患者报告结果和生活质量评估:多中心前性研究
Ghaithiry Selvarajoo1, Mee Hoong See1,2,3, Lee Lee Lai4
1Department of Surgery, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
World journal of surgery
|August 22, 2025
概括
与乳房切除相比, 乳房保护手术 (BCS) 导致马来西亚乳腺癌患者的生活质量和满意度提高. 这种工具有助于手术决策.
科学领域:
- 癌症学
- 手术的结果
- 患者报告的结果
背景情况:
- 乳腺癌是全球和马来西亚女性最常见的癌症.
- 患者报告的结果 (PROs),如生活质量 (QOL) 和满意度,对于评估乳腺癌手术的有效性至关重要.
- BREAST-Q是一个验证的工具来评估患者对手术结果的看法.
研究的目的:
- 在马来西亚乳腺癌患者的乳房切除和乳房保护手术 (BCS) 之间比较QOL和满意度.
- 评估BREAST-Q在评估不同乳腺癌手术结果中的有用性.
主要方法:
- 一项多中心前性队列研究,涉及230名乳腺癌0-III期的妇女.
- 患者在2022年1月至2023年4月期间接受了乳房切除或BCS.
- 在手术前和手术后6个月和12个月进行了BREAST- Q问卷调查,使用t测试和ANOVA分析数据.
主要成果:
- 与乳房切除手术患者相比,乳房切除手术患者的整体QOL和满意度显著提高.
- 在所有术后阶段,BCS对心理社会和性健康都有特别的益处.
- 在12个月后,身体健康有利于BCS,而乳腺切除术患者对手术团队的满意度更高.
结论:
- 与乳腺癌治疗的乳腺切除术相比,BCS与患者满意度和QOL更高相关.
- BREAST-Q是增强患者与外科医生的沟通,并为外科选择提供信息的重要工具.
- 这些发现支持BCS作为有益的手术选择,改善了患者的准备和决策.
更多相关视频
06:03Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
6.7K
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
2.9K
相关概念视频
SBAR II: Application of SBAR
4.7K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
4.7K
Cancer Survival Analysis
453
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
453
